创胜集团 - 全整合型国际化生物制药公司
创胜集团, 生物药, 抗体, 药物研发
2019 年 10 月 30 日
The FDA last year pulled together the best people from among a number of agencies to try to figure out what could be done about perpetual drugs shortages that create dangers for patients and struggles for doctors and hospitals. After a year of study, its conclusion is that the subject needs more study.
The FDA Tuesday dropped its report Drug Shortages: Root Causes and Potential Solutionswith the explanation that includes suggestions that might help relieve chronic shortages but acknowledging that there has never really been any “private- or public-sector effort to collect and analyze comprehensive information to characterize shortages, quantify their effects, or closely observe the contracting practices that may be driving them.”